Attached files

file filename
8-K - 8-K - Zovio Inczvo-20210224.htm
Exhibit 99.1
zovio-logoa041.jpg
For Immediate Release
Contact: Alanna Vitucci
alanna.vitucci@zovio.com
858 668 2586 x11636

Zovio Inc Reports Fourth Quarter and Full Year 2020 Results
Zovio Growth segment continues to exceed expectations, delivering 105% revenue growth in 2020

CHANDLER, Ariz. (February 24, 2021) - Zovio Inc (NASDAQ:ZVO), an education technology services company, today announced the results for its fourth quarter and full year ended December 31, 2020.
We ended the year strong, executing on the sale of the University, delivering triple-digit growth in Zovio Growth and exceeding earnings expectations. Zovio is an enviable position as we embark on this new chapter as a leading education technology services business. Our track record of innovation, driven by advanced data and analytics, strong culture and more than 200 institutional partners will allow us to offer services to our university partners that span the student journey and support the best possible outcomes. As we enter 2021, we remain poised for long-term growth and value-creation as we capture the rapid changes in education to empower all learners,” commented Andrew Clark, Founder, President and Chief Executive Officer.

Financial Results for the Three Months Ended December 31, 2020
Revenue and other revenue for the three months ended December 31, 2020 was $93.1 million, compared with revenue of $96.3 million for the three months ended December 31, 2019.
Operating loss for the three months ended December 31, 2020 was $57.3 million, compared with operating loss of $21.2 million for the three months ended December 31, 2019.
The Company recognized an income tax benefit of approximately $0.2 million for the three months ended December 31, 2020, compared with income tax expense of $1.8 million for the three months ended December 31, 2019.
Net loss for the three months ended December 31, 2020 was $57.2 million, compared with net loss of $23.0 million for the three months ended December 31, 2019.
Diluted loss per share for the three months ended December 31, 2020 was $1.75, compared with diluted loss per share of $0.76 for the three months ended December 31, 2019.
Non-GAAP Financial Results for the Three Months Ended December 31, 2020
Non-GAAP operating income for the three months ended December 31, 2020 was $0.9 million, compared with non-GAAP operating loss of $4.4 million for the three months ended December 31, 2019. Non-GAAP operating income for the three months ended December 31, 2020 excludes restructuring and impairment charges of $1.4 million, separation transaction costs of $1.2 million, acquisition costs of $0.9 million and loss on transaction of $54.8 million. Non-GAAP operating loss for the three months ended December 31, 2019 excludes restructuring and impairment charges of $13.6 million, separation transaction costs of $0.9 million and acquisition costs of $2.4 million.
Non-GAAP net income for the three months ended December 31, 2020 was $0.9 million, compared with non-GAAP net loss of $4.5 million for the three months ended December 31, 2019. Non-GAAP net income for the three months ended December 31, 2020 excludes restructuring and impairment charges of $1.4 million, separation transaction costs of $1.2 million and acquisition costs of $0.9 million, loss on transaction of $54.8 million and the related tax effects. Non-GAAP net loss for the three months ended December 31, 2019 excludes restructuring and impairment charges of $13.6 million, separation transaction costs of $0.9 million, acquisition costs of $2.4 million and the related tax effects.


Exhibit 99.1
Non-GAAP diluted income per share for the three months ended December 31, 2020 was $0.03, compared with non-GAAP diluted loss per share of $0.15 for the three months ended December 31, 2019.
Financial Results for the Year Ended December 31, 2020
Revenue and other revenue for the year ended December 31, 2020 was $397.1 million, compared with revenue of $417.8 million for the year ended December 31, 2019.
Operating loss for the year ended December 31, 2020 was $61.9 million, compared with operating loss of $56.6 million for the year ended December 31, 2019.
The Company recognized an income tax benefit of $13.1 million for the year ended December 31, 2020, compared with income tax benefit of $0.8 million for the year ended December 31, 2019.
Net loss for the year ended December 31, 2020 was $49.0 million, compared with net loss of $54.8 million for the year ended December 31, 2019.
Diluted loss per share for the year ended December 31, 2020 was $1.53, compared with diluted loss per share of $1.86 for the year ended December 31, 2019.
Non-GAAP Financial Results for the Year Ended December 31, 2020
Non-GAAP operating income for the year ended December 31, 2020 was $8.8 million, compared with non-GAAP operating loss of $15.0 million for the year ended December 31, 2019. Non-GAAP operating income for the year ended December 31, 2020 excludes restructuring and impairment charges of $4.8 million, separation transaction costs of $6.7 million, acquisition costs of $4.3 million and loss on transaction of $54.8 million. Non-GAAP operating loss for the year ended December 31, 2019 excludes restructuring and impairment charges of $21.5 million, separation transaction costs of $5.8 million, acquisition costs of $14.1 million and other non-GAAP costs of $0.2 million.
Non-GAAP net income for the year ended December 31, 2020 was $8.6 million, compared with non-GAAP net loss of $13.9 million for the year ended December 31, 2019. Non-GAAP net income for the year ended December 31, 2020 excludes restructuring and impairment charges of $4.8 million, separation transaction costs of $6.7 million, acquisition costs of $4.3 million, loss on transaction of $54.8 million, and the related tax effects. Non-GAAP net loss for the year ended December 31, 2019 excludes restructuring and impairment charges of $21.5 million, separation transaction costs of $5.8 million, acquisition costs of $14.1 million, other non-GAAP costs of $0.2 million and the related tax effects.
Non-GAAP diluted income per share for the year ended December 31, 2020 was $0.27, compared with non-GAAP diluted loss per share of $0.47 for the year ended December 31, 2019.
Balance Sheet and Cash Flow
As of December 31, 2020, the Company had cash and cash equivalents of $35.5 million as compared to $69.3 million as of December 31, 2019.
The Company had $25.3 million of cash provided by operating activities during the year ended December 31, 2020, compared with $46.1 million of cash used in operating activities during the year ended December 31, 2019.
About Non-GAAP Financial Measures
This press release contains non-GAAP financial measures for non-GAAP operating income (loss), non-GAAP net income (loss), non-GAAP diluted income (loss) per share, EBITDA and Adjusted EBITDA. These non-GAAP measures exclude restructuring and impairment charges, separation transaction costs, acquisition costs, loss on transaction, as well as certain income tax adjustments, as applicable. These non-GAAP financial measures are not prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and are not based on a comprehensive set of accounting rules. Management believes non-GAAP financial measures are useful in providing investors with an understanding of how specific line items in the consolidated statements of income are affected by items that may not be indicative of the operating results of the Company’s core business. To the extent that other companies use similar methods in calculating and reporting non-GAAP operating results, the Company believes provision of supplemental non-GAAP financial information allows for a meaningful comparison of the Company’s performance against the performance of other companies. The Company further believes that these non-GAAP


Exhibit 99.1
financial measures provide useful information regarding its ongoing operating activities and business trends related to its results of operations, as well as a meaningful comparison with historical financial results. The Company’s management and board of directors utilize these non-GAAP financial measures, together with the Company’s financial statements prepared in accordance with GAAP, in developing operating budgets and evaluating the Company’s performance. These non-GAAP financial measures are intended to supplement GAAP financial information, and should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. In addition, these non-GAAP financial measures may be different from non-GAAP financial measures used by other companies. Refer to the accompanying tables for a detailed reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures.
Earnings Conference Call and Webcast
Zovio Inc will host a conference call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) today to discuss its latest financial results and recent highlights. The dial-in number for callers in the United States is (877) 395-6119, and the dial-in number for other callers is (647) 689-5537. The access code for all callers is 4834547. A live broadcast of the call will also be available on the Company’s website at http://ir.zovio.com.
About Zovio Inc
Zovio Inc (NASDAQ: ZVO) is an education technology services company that partners with higher education institutions and employers to deliver innovative, personalized solutions to help learners and leaders achieve their aspirations. The Zovio network, which includes Fullstack Academy and TutorMe, leverages its core strengths and applies its technology and capabilities to priority market needs. Using advanced data and analytics, Zovio identifies the most meaningful ways to enhance the learner experience and deliver strong outcomes for higher education institutions, employers, and learners. Zovio's purpose is to help everyone be in a class of their own. For more information, visit www.zovio.com.

Forward-Looking Statements
This news release may contain forward-looking statements which are not statements of historical fact and are subject to the Safe Harbor provisions created by the Private Securities Litigation Reform Act of 1995, including, without limitation, statements regarding management’s intentions, hopes, beliefs or expectations, and statements regarding the Company’s outlook for the remainder of 2021 and beyond. These forward-looking statements are based on current information and expectations and are subject to various risks and uncertainties. The Company’s actual performance or results may differ materially from those expressed in or suggested by such statements due to various factors, including without limitation: our ability to successfully transition to being an education technology services company, and the success of our strategies with respect to student initiatives.
Additional information on factors that could cause actual plans implemented and actual results achieved to differ materially from those set forth in the forward-looking statements is included from time to time in the Company’s filings with the Securities and Exchange Commission (“SEC”), including, but not limited to, the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 to be filed with the SEC on February 24, 2021, the Company’s quarterly reports on Form 10-Q and the Company’s current reports on Form 8-K which are available at www.zovio.com. You should not place undue reliance on any forward-looking statements. Forward-looking statements are made on the basis of management’s good faith beliefs, expectations and assumptions regarding future events based on information available at the time such statements are made. Forward-looking statements speak only as of the date they are made. The Company assumes no obligation to update or revise any forward-looking statements to reflect actual results or any changes in assumptions, expectations or other factors affecting such forward-looking statements, except to the extent required by applicable securities laws.


Exhibit 99.1

ZOVIO INC
Consolidated Statements of Income (Loss)
(In thousands, except per share amounts)

 Three Months Ended
December 31,
Year Ended
December 31,
 2020201920202019
University Partners segment revenue$87,401 $92,307 $376,220 $407,594 
Zovio Growth segment revenue5,742 3,978 20,901 10,201 
Revenue and other revenue93,143 96,285 397,121 417,795 
Costs and expenses:   
Technology and academic services19,591 17,944 74,412 73,342 
Counseling services and support25,467 25,231 96,996 110,256 
Marketing and communication21,603 19,451 91,620 96,001 
General and administrative10,947 13,018 47,352 56,840 
University-related expense16,669 28,290 89,001 116,488 
Restructuring and impairment charges1,413 13,575 4,843 21,465 
Loss on transaction54,797 — 54,797 — 
Total costs and expenses150,487 117,509 459,021 474,392 
Operating loss(57,344)(21,224)(61,900)(56,597)
Other income (loss), net(58)(25)(120)1,015 
Loss before income taxes(57,402)(21,249)(62,020)(55,582)
Income tax expense (benefit)(162)1,766 (13,068)(770)
Net loss$(57,240)$(23,015)$(48,952)$(54,812)
Loss per share:
Basic$(1.75)$(0.76)$(1.53)$(1.86)
Diluted$(1.75)$(0.76)$(1.53)$(1.86)
Weighted average number of common shares outstanding used in computing loss per share:  
Basic32,697 30,270 31,959 29,492 
Diluted32,697 30,270 31,959 29,492 




Exhibit 99.1
ZOVIO INC
Consolidated Balance Sheets
(In thousands)

As of December 31,
20202019
ASSETS  
Current assets:  
Cash and cash equivalents$35,462 $69,280 
Restricted cash20,035 23,257 
Investments1,515 2,502 
Accounts receivable, net7,204 34,951 
Prepaid expenses and other current assets12,617 20,524 
Total current assets76,833 150,514 
Property and equipment, net30,575 34,294 
Operating lease assets20,114 18,615 
Goodwill and intangibles, net31,785 44,419 
Other long-term assets1,999 2,296 
Total assets$161,306 $250,138 
LIABILITIES AND STOCKHOLDERS' EQUITY  
Current liabilities:  
Accounts payable and accrued liabilities$62,693 $68,160 
Deferred revenue and student deposits8,090 55,284 
Total current liabilities70,783 123,444 
Rent liability24,125 22,409 
Other long-term liabilities7,181 5,347 
Total liabilities102,089 151,200 
Total stockholders' equity59,217 98,938 
Total liabilities and stockholders' equity$161,306 $250,138 



Exhibit 99.1
ZOVIO INC
Consolidated Statements of Cash Flows
(In thousands)

 Year Ended December 31,
 20202019
Cash flows from operating activities  
Net loss$(48,952)$(54,812)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for bad debts14,256 16,252 
Depreciation and amortization11,403 10,229 
Deferred income taxes119 (36)
Stock-based compensation8,291 12,340 
Noncash lease expense10,644 19,261 
Net loss (gain) on marketable securities(111)(308)
Reassessment of lease charges— 558 
Loss on disposal or impairment38 878 
Loss on transaction51,952 — 
Changes in operating assets and liabilities:
  Accounts receivable(17,666)(18,537)
  Prepaid expenses and other current assets10,339 3,874 
  Other long-term assets(1,241)(7)
  Accounts payable and accrued liabilities(4,978)1,939 
  Deferred revenue and student deposits1,706 (11,099)
  Operating lease liabilities(10,751)(22,967)
  Other liabilities277 (3,651)
Net cash provided by (used in) operating activities25,326 (46,086)
Cash flows from investing activities  
Capital expenditures(3,153)(31,029)
Purchases of investments(720)(126)
Cash transferred in connection with disposition(62,325)— 
Capitalized costs for intangible assets(272)(750)
Cash paid for acquisitions, net of cash acquired— (19,489)
Sales of investments1,818 — 
Net cash used in investing activities(64,652)(51,394)
Cash flows from financing activities  
Proceeds from exercise of stock options60 
Proceeds from the issuance of stock under employee stock purchase plan209 192 
Borrowings from notes payable2,682 — 
Tax withholding on issuance of stock awards(507)(819)
Repurchase of common stock(106)— 
Net cash provided by (used in) financing activities2,286 (567)
Net decrease in cash, cash equivalents and restricted cash(37,040)(98,047)
Cash, cash equivalents and restricted cash at beginning of period92,537 190,584 
Cash, cash equivalents and restricted cash at end of period$55,497 $92,537 



Exhibit 99.1
ZOVIO INC
Reconciliation of GAAP to Non-GAAP Financial Measures
(In thousands, except per share amounts)
(Unaudited)


 Three Months Ended
December 31,
Year Ended
December 31,
 2020201920202019
Operating Income (Loss) Reconciliation:
GAAP operating loss$(57,344)$(21,224)$(61,900)$(56,597)
Restructuring and impairment charges1,413 13,575 4,843 21,465 
Separation transaction costs1,157 874 6,731 5,832 
Acquisition costs874 2,404 4,298 14,111 
Other non-GAAP costs— — — 238 
Loss on transaction54,797 — 54,797 — 
Non-GAAP operating income (loss)$897 $(4,371)$8,769 $(14,951)
Net Income (Loss) Reconciliation:
GAAP net loss$(57,240)$(23,015)$(48,952)$(54,812)
Restructuring and impairment charges1,413 13,575 4,843 21,465 
Separation transaction costs1,157 874 6,731 5,832 
Acquisition costs874 2,404 4,298 14,111 
Other non-GAAP costs— — — 238 
Loss on transaction54,797 — 54,797 — 
Income tax impact, non-GAAP(89)1,663 (13,122)(750)
Non-GAAP net income (loss)$912 $(4,499)$8,595 $(13,916)
Diluted Income (Loss) Per Share Reconciliation:
GAAP diluted loss per share$(1.75)$(0.76)$(1.53)$(1.86)
Restructuring and impairment charges0.04 0.45 0.15 0.73 
Separation transaction costs0.04 0.03 0.21 0.20 
Acquisition costs0.03 0.08 0.13 0.48 
Other non-GAAP costs— — — 0.01 
Loss on transaction1.68 — 1.72 — 
Income tax impact, non-GAAP(0.01)0.05 (0.41)(0.03)
Non-GAAP diluted income (loss) per share$0.03 $(0.15)$0.27 $(0.47)



Exhibit 99.1
ZOVIO INC
Reconciliation of GAAP to Non-GAAP Financial Measures (continued)
(In thousands, except per share amounts)
(Unaudited)


Three Months Ended
December 31,
Year Ended
December 31,
2020201920202019
EBITDA and Adjusted EBITDA Reconciliation:
GAAP net loss$(57,240)$(23,015)$(48,952)$(54,812)
Interest expense (income), net58 (91)120 (910)
Income tax expense (benefit)(162)1,766 (13,068)(770)
Depreciation and amortization2,655 3,055 11,403 10,229 
EBITDA(54,689)(18,285)(50,497)(46,263)
Restructuring and impairment charges1,413 13,575 4,843 21,465 
Separation transaction costs1,157 874 6,731 5,832 
Acquisition costs42 1,570 971 11,613 
Other non-GAAP costs— — — 238 
Loss on transaction54,797 — 54,797 — 
Adjusted EBITDA$2,720 $(2,266)$16,845 $(7,115)